 A number of research firms have changed their ratings and price targets for Agios Pharmaceuticals NASDAQ: AGIO: 812020 Agios Pharmaceuticals was downgraded by analysts at BidaskClub from a hold rating to a sell rating. 7312020 Agios Pharmaceuticals had its price target raised by analysts at Cantor Fitzgerald from 70.00 to 72.00. They now ... 